COVID-19 has upended the world and proven to be a difficult disease to understand and contain. When a research team at the National Center for Advancing Translational Sciences (NCATS), a part of the NIH, was tasked to help find a possible therapeutic, they turned to PerkinElmer’s AlphaLISA® assay technology and embarked on a drug repurposing strategy as the quickest route to generating data that would help the pharma industry drive towards an effective treatment.

Join for free to read